Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small<scp>‐</scp>cell lung cancer in KEYNOTE‐407Shunichi Sugawara, Terufumi Kato, Tomonori Hirashima et al.|Cancer Science|2023Cited by 16
Contribution of nationwide genome screening in Japan (LC-SCRUM-Japan) to the development of precision medicine for non-small cell lung cancer.Takashi Seto, Kōichi Goto, Shingo Matsumoto et al.|Journal of Clinical Oncology|2018Cited by 7
Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).Shingo Matsumoto, Kōichi Goto, Kiyotaka Yoh et al.|Journal of Clinical Oncology|2015Cited by 4